Patents by Inventor Dale F. Gruber

Dale F. Gruber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110183375
    Abstract: The present invention is directed generally to metal binding compounds which may be added to cell culture media to replace factors required for cultivation of the cells (e.g. transferrin) which are of animal or human origin. More specifically, the invention is directed to metal binding compounds or complexes thereof comprising one or more transition element cations (such as ferrous or ferric ions), which are added to cell and tissue culture medium compositions. The metal binding compounds may be added to the media alone or may be first complexed with a transition metal ion. The invention is also directed to methods of use of such compositions, including, for example, methods for the cultivation of eukaryotic cells, particularly animal cells, in vitro. The invention also relates to compositions comprising such culture media and one or more cells, and to kits comprising one or more of the above-described compositions.
    Type: Application
    Filed: January 25, 2011
    Publication date: July 28, 2011
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: David A. Epstein, Paul J. Battista, Dale F. Gruber, David A. Judd
  • Publication number: 20080286868
    Abstract: The present invention is directed generally to metal binding compounds which may be added to cell culture media to replace factors required for cultivation of the cells (e.g. transferrin) which are of animal or human origin. More specifically, the invention is directed to metal binding compounds or complexes thereof comprising one or more transition element cations (such as ferrous or ferric ions), which are added to cell and tissue culture medium compositions. The metal binding compounds may be added to the media alone or may be first complexed with a transition metal ion. The invention is also directed to methods of use of such compositions, including, for example, methods for the cultivation of eukaryotic cells, particularly animal cells, in vitro. The invention also relates to compositions comprising such culture media and one or more cells, and to kits comprising one or more of the above-described compositions.
    Type: Application
    Filed: June 9, 2008
    Publication date: November 20, 2008
    Applicant: INVITROGEN CORPORATION
    Inventors: David A. Epstein, Paul J. Battista, Dale F. Gruber, David A. Judd
  • Patent number: 7217566
    Abstract: The present invention provides novel cell lines that may have improved adhesive qualities, transgene expression level, growth rate, and/or growth rate in serum free medium or even chemically defined compared to cells of the prior art.
    Type: Grant
    Filed: March 22, 2004
    Date of Patent: May 15, 2007
    Assignee: Invitrogen Corporation
    Inventors: Sharon Cates, Valentina C. Ciccarone, Dale F. Gruber, Pamela Hawley-Nelson
  • Publication number: 20040214327
    Abstract: The present invention is directed generally to metal binding compounds which may be added to cell culture media to replace factors required for cultivation of the cells (e.g. transferrin) which are of animal or human origin. More specifically, the invention is directed to metal binding compounds or complexes thereof comprising one or more transition element cations (such as ferrous or ferric ions), which are added to cell and tissue culture medium compositions. The metal binding compounds may be added to the media alone or may be first complexed with a transition metal ion. The invention is also directed to methods of use of such compositions, including, for example, methods for the cultivation of eukaryotic cells, particularly animal cells, in vitro. The invention also relates to compositions comprising such culture media and one or more cells, and to kits comprising one or more of the above-described compositions.
    Type: Application
    Filed: May 26, 2004
    Publication date: October 28, 2004
    Inventors: David A. Epstein, Paul J. Battista, Dale F. Gruber, David A. Judd
  • Patent number: 6767741
    Abstract: The present invention is directed generally to metal binding compounds which may be added to cell culture media to replace factors required for cultivation of the cells (e.g. transferrin) which are of animal or human origin. More specifically, the invention is directed to metal binding compounds or complexes thereof comprising one or more transition element cations (such as ferrous or ferric ions), which are added to cell and tissue culture medium compositions. The metal binding compounds may be added to the media alone or may be first complexed with a transition metal ion. The invention is also directed to methods of use of such compositions, including, for example, methods for the cultivation of eukaryotic cells, particularly animal cells, in vitro. The invention also relates to compositions comprising such culture media and one or more cells, and to kits comprising one or more of the above-describcd compositions.
    Type: Grant
    Filed: August 28, 2000
    Date of Patent: July 27, 2004
    Assignee: Invitrogen Corporation
    Inventors: David A. Epstein, Paul J. Battista, Dale F. Gruber, David A. Judd